<DOC>
	<DOCNO>NCT01997996</DOCNO>
	<brief_summary>Transvaginal mesh ( TVM ) indicate treatment pelvic organ prolapse ( POP ) surgical intervention necessary . Due potential risk de novo dyspareunia , TVM mainly use postmenopausal woman case recurrent POP . PROLIFT+M ( Trademark ) base highly flexible material partially absorbable . We suggest PROLIFT+M less impact vita sexualis conventional TVM could also use treatment young and/or sexually active woman . This study observe woman routinely treat PROLIFT+M regard sexual function surgery . The hypothesis worsen vita sexualis PROLIFT+M .</brief_summary>
	<brief_title>ProViS ( Prolift+M Vita Sexualis ) Study</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<criteria>The patient understand nature content trial POP ≥ stage II ( accord POPQ system ( 18 ) ) Sexual intercourse ≥ 2x/4 week Written inform consent Negative pregnancy test woman childbearing potential Women ≥ 18 year Concomitant surgery inner genitalis ( e.g . colporrhaphy , sacrocolpopexy , sacrospinous fixation , hysterectomy ) ; concomitant suburethral sling bulk agent allow Unable read speak German Women &lt; 18 year Women pregnant breastfeed planning future pregnancy Acute infection ( ) , e.g . untreated urogenital infection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Pelvic Organ Prolapse</keyword>
	<keyword>PROLIFT+M</keyword>
	<keyword>Vita sexualis</keyword>
</DOC>